The authors reply

New England Journal of Medicine

Volumn 369, Issue 12, 2013, Pages 1171-1172

  Yong, Kol Jia ^a   Chai, Li ^b   Tenen, Daniel G ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYTOKERATIN 19; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TBX3; UNCLASSIFIED DRUG;

ALPHA FETOPROTEIN BLOOD LEVEL; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER SURGERY; COHORT ANALYSIS; CORRELATION ANALYSIS; GENE EXPRESSION; GENE FUNCTION; HONG KONG; HUMAN; LETTER; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALL4 GENE; SENSITIVITY AND SPECIFICITY; UPREGULATION;

EID: 84884193114     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1308785     Document Type: Letter

References (3)

1. Panis C, Pizzatti L, Herrera AC, Cecchini R, Abdelhay E. Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics. Cancer Lett 2013;330:57-66.
2. Oikawa T, Kamiya A, Zeniya M, et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 2013;57:1469-83.
3. Chen CL, Tsukamoto H, Liu JC, et al. Reciprocal regulation by TLR4 and TGF-â in tumor-initiating stem-like cells. J Clin Invest 2013;123:2832-49.